| Ian Honaker, | |
|
202 Guadalcanal Ave, Beckley, WV 25801-8060 | |
| (304) 228-7620 | |
| Not Available |
| Full Name | Ian Honaker |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 3 Years |
| Location | 202 Guadalcanal Ave, Beckley, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336593359 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| 390200000X | Student In An Organized Health Care Education/training Program | 21030312600 (West Virginia) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Greenbrier Valley Physical Therapy Llc | 3870499957 | 35 |
News Archive
For the last decade, prematurity has been the leading cause of infant mortality in the United States. As a result of prematurity many infants enter this world too early with a small chance of survival. In order to help treat these extremely premature infants, physicians at Nationwide Children's Hospital developed a set of guidelines tailored to meet the needs of these tiny infants, some born up to four months early.
Four-year results for an ongoing study of second-line bosutinib indicate that the tyrosine kinase inhibitor offers long-term efficacy with manageable side effects for patients with chronic phase chronic myeloid leukaemia.
Immunology researchers at UT Southwestern Medical Center have found that bacteria present in the human gut help initiate the body's defense mechanisms against Toxoplasma gondii, the parasite responsible for toxoplasmosis.
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application for the generic version of Doryx® (doxycyline hyclate delayed-release) 75 and 100mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.
One group of drugs that is effective in fighting HIV may, paradoxically, also be promoting the death of sensory nerves in the skin, according to a study presented October 5, 2004, at the 129th annual meeting of the American Neurological Association in Toronto.
› Verified 2 days ago
| Provider Name | Greenbrier Valley Physical Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1619260353 PECOS PAC ID: 3870499957 Enrollment ID: O20031209001137 |
News Archive
For the last decade, prematurity has been the leading cause of infant mortality in the United States. As a result of prematurity many infants enter this world too early with a small chance of survival. In order to help treat these extremely premature infants, physicians at Nationwide Children's Hospital developed a set of guidelines tailored to meet the needs of these tiny infants, some born up to four months early.
Four-year results for an ongoing study of second-line bosutinib indicate that the tyrosine kinase inhibitor offers long-term efficacy with manageable side effects for patients with chronic phase chronic myeloid leukaemia.
Immunology researchers at UT Southwestern Medical Center have found that bacteria present in the human gut help initiate the body's defense mechanisms against Toxoplasma gondii, the parasite responsible for toxoplasmosis.
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application for the generic version of Doryx® (doxycyline hyclate delayed-release) 75 and 100mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.
One group of drugs that is effective in fighting HIV may, paradoxically, also be promoting the death of sensory nerves in the skin, according to a study presented October 5, 2004, at the 129th annual meeting of the American Neurological Association in Toronto.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ian Honaker, 202 Guadalcanal Ave, Beckley, WV 25801-8060 Ph: (304) 228-7620 | Ian Honaker, 202 Guadalcanal Ave, Beckley, WV 25801-8060 Ph: (304) 228-7620 |
News Archive
For the last decade, prematurity has been the leading cause of infant mortality in the United States. As a result of prematurity many infants enter this world too early with a small chance of survival. In order to help treat these extremely premature infants, physicians at Nationwide Children's Hospital developed a set of guidelines tailored to meet the needs of these tiny infants, some born up to four months early.
Four-year results for an ongoing study of second-line bosutinib indicate that the tyrosine kinase inhibitor offers long-term efficacy with manageable side effects for patients with chronic phase chronic myeloid leukaemia.
Immunology researchers at UT Southwestern Medical Center have found that bacteria present in the human gut help initiate the body's defense mechanisms against Toxoplasma gondii, the parasite responsible for toxoplasmosis.
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application for the generic version of Doryx® (doxycyline hyclate delayed-release) 75 and 100mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.
One group of drugs that is effective in fighting HIV may, paradoxically, also be promoting the death of sensory nerves in the skin, according to a study presented October 5, 2004, at the 129th annual meeting of the American Neurological Association in Toronto.
› Verified 2 days ago
Mrs. Angela Michelle Strickland, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2233 S Kanawha St, Beckley, WV 25801 Phone: 304-255-9248 Fax: 304-255-9237 | |
Catherine Canizares, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 250 Stanaford Rd, Beckley, WV 25801 Phone: 304-255-3302 Fax: 304-254-2783 | |
Adriel R. Green, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 9 Yellow Wood Way, Beckley, WV 25801 Phone: 304-255-2376 Fax: 304-255-7120 | |
Jukey Dotson, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 423 Carriage Dr, Beckley, WV 25801 Phone: 304-253-7246 Fax: 304-253-7250 | |
Charles Dodson, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 400 Neville St, Beckley, WV 25801 Phone: 304-256-4712 | |
John Beasley, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 423 Carriage Dr, Beckley, WV 25801 Phone: 304-253-7246 Fax: 304-253-7250 | |
Michael P Bates, PT CCM Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 9 Yellow Wood Way, Beckley, WV 25801 Phone: 304-255-2376 Fax: 304-255-7120 |